CRISPR Therapeutics AG (CRSP) Corporate Subsidiaries
CRISPR Therapeutics AG (CRSP) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRSP
CIK: 1674416
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerVictoria Forward
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-14 | 4 | 0001193125-26-424317 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-13 | 4 | 0001193125-26-423057 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-13 | 4 | 0001193125-26-423056 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001950047-26-010218 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418101 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001950047-26-010087 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 | 0001193125-26-401237 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009755 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396944 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2025-08-06 | 4 | 0001193125-26-396935 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009604 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000940594-26-000049 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 | 0001193125-26-345111 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001193125-26-330672 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330644 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002146 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264390 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264382 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264290 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264289 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264288 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264287 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264286 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264285 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264282 | View SEC Doc Filr Page |